|
| Exchange Received Time 10/08/2018 20:20:39 Exchange Disseminated Time 10/08/2018 20:20:41 Time Taken 00:00:02 | Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is to inform you that the Board of Glenmark Pharmaceuticals Limited (the "Company") at its meeting held today approved the transaction, the details of which are mentioned in the Annexure A.
The said Annexure is pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The press release in this regard is also attached as Annexure B.
You are requested to kindly take note of the same.
|
|
|